Transient expression of SV 40 large T antigen by Cre/LoxP-mediated site-specific deletion in primary human tumor cells

Human Gene Therapy

Volumn 8, Issue 14, 1997, Pages 1695-1700

  Schlag, Peter M ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; HYGROMYCIN; PUROMYCIN; RECOMBINASE; THYMIDINE KINASE; TUMOR VACCINE; VIRUS LARGE T ANTIGEN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; BACTERIOPHAGE; BREAST CANCER; CELL IMMORTALIZATION; CELL STRAIN 3T3; COLON CANCER; ENZYME SUBSTRATE; FIBROBLAST CULTURE; GENE DELETION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; KIDNEY CELL; MITOSIS INHIBITION; MOUSE; NONHUMAN; RETROVIRUS; SIMIAN VIRUS 40; SITE DIRECTED MUTAGENESIS; TUMOR CELL;

EID: 17344363706     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.14-1695     Document Type: Article

References (3)

1. BERGEMANN, J., KÜHLCKE, K., FEHSE, B., RATZ, I., OSTERTAG, W., and LOTHAR, H. (1995). Excision of specific DNA-sequences from integrated retroviral vectors via site-specific recombination. Nucleic Acids Res. 23, 4451-4456.
2. BLANKENSTEIN, T., CAYEUX, S., and QIN, Z. (1996). Genetic approaches to cancer immunotherapy. Rev. Physiol. Biochem. Pharmacol. 129, 1-49.
3. URBAN, J.L., and SCHREIBER, H. (1992). Tumor antigens. Annu. Rev. Immunol. 10, 617-644.